Legal Opinion
Purdue Pharma L.P. v. Epic Pharma, LLC
Court of Appeals for the Federal Circuit
Decided February 1, 2016No. 2014-1294, 2014-1307, 2014-1313, 2014-1296, 2014-1311, 2014-1314, 2014-1306, 2014-1312PublishedCited by 22 opinions
1Opinion of the Court
PROST, Chief Judge.
This appeal arises from consolidated Hatch-Waxman proceedings involving the reformulated version of the pain reliever OxyContin®. The Appellants, Purdue Pharma L.P., The P.F. Laboratories, Inc., Purdue Pharmaceuticals L.P., and Rhodes Technologies (collectively, “Purdue”) and Grunenthal GmbH (“Grunenthal”) asserted a number of claims from multiple different patents against the Appellees, Amneal Pharmaceuticals, LLC (“Amneal”), Epic Pharma, LLC (“Epic”), Mylan Pharmaceuticals Inc. and Mylan Inc. (collectively, “Mylan”), and Teva Pharmaceuticals USA, Inc. (“Teva”), all of…
2Cases cited12 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Eibel Process Co. v. Minnesota & Ontario Paper Co.Supreme Court of the United States · 1923
- Smithkline Beecham Corp. v. Apotex [Corrected Date]Court of Appeals for the Federal Circuit · 2006
- Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
7 more not listed; retrieve them via the Exa API.
3Cited by22 opinions
- Koninklijke Philips N v. v. Google LLCCourt of Appeals for the Federal Circuit · 2020
- In re Biogen 755 Patent Litig.District Court, D. New Jersey · 2018
- Kamstrup A/S v. Axioma Metering UabCourt of Appeals for the Federal Circuit · 2022
- Biogen Ma Inc. v. Emd Serono, Inc.Court of Appeals for the Federal Circuit · 2020
- Purdue Pharma L.P. v. Collegium Pharm., Inc.District Court, District of Columbia · 2018
17 more not listed; retrieve them via the Exa API.